Cathie Wood’s ARK funds trimmed major semiconductor holdings while adding to newly public Cerebras Systems, sharpening Wall Street’s focus on one of the year’s most closely watched artificial intelligence trades. The move comes days after Cerebras completed a blockbuster Nasdaq debut under the ticker CBRS, giving investors a fresh public-market benchmark for demand beyond Nvidia and other established chip leaders.
ARK Cuts AMD While Buying Cerebras
The latest ARK trading disclosure showed the firm selling Advanced Micro Devices shares and increasing its position in Cerebras Systems across flagship innovation-focused exchange-traded funds. The largest disclosed purchase was 149,176 CBRS shares, valued at roughly $46.4 million based on the trade disclosure.
That buying followed an earlier ARK purchase of 105,616 Cerebras shares shortly after the company’s debut. The combined activity signals that Wood’s funds are rotating at least part of their semiconductor exposure toward a newly listed AI infrastructure name rather than simply adding to long-established chipmakers.
ARK also trimmed other semiconductor-related positions, including Taiwan Semiconductor Manufacturing and Teradyne in recent trading disclosures. The sales do not necessarily mean the firm has turned bearish on the chip sector. They suggest a rebalancing toward companies with a more direct narrative around next-generation AI computing.
Cerebras Stock Remains Volatile After IPO Surge
Cerebras priced its IPO at $185 per share on May 13, 2026, raising about $5.55 billion. The listing was the largest U.S. IPO of the year so far and was heavily oversubscribed, reflecting strong demand for artificial intelligence infrastructure companies.
CBRS began trading on May 14 and opened near $350 before ending its first session at $311.07, up about 68% from the IPO price. The early surge briefly pushed the company’s public valuation toward the upper end of expectations, though trading has remained volatile.
By the latest market close on May 15, CBRS was trading at $279.72 after opening the session at $299.30. The stock’s intraday range, from about $275.76 to $333.00, underscored how aggressively investors are trying to price a company with large ambitions, limited public trading history and significant exposure to the AI buildout.
Why Cerebras Has Become An AI Market Test
Cerebras Systems, based in Sunnyvale, California, builds specialized processors designed for artificial intelligence workloads. Its core pitch centers on wafer-scale chips, a design approach that uses a much larger silicon footprint than conventional graphics processors.
The company’s technology has drawn attention because investors are searching for credible alternatives or complements to Nvidia, which remains the dominant supplier of AI accelerators. Cerebras is not yet a comparable public-market giant, but its IPO gives investors a listed company tied directly to the AI inference and data-center expansion theme.
The company generated $510 million in revenue in 2025, up from $290.3 million in 2024. That growth rate helps explain the intense IPO demand, but the valuation also raises the stakes. At the IPO price and first-day trading levels, investors were valuing Cerebras at a high multiple of trailing revenue, leaving little room for execution missteps.
The Bull Case And The Risks
The bullish argument is straightforward: AI models are becoming more expensive to train and run, data centers need more specialized computing capacity, and customers may increasingly seek suppliers beyond the current market leaders. Cerebras sits directly in that debate.
The risk case is just as important. Newly public AI infrastructure companies can face sharp swings when expectations move faster than revenue, margins or customer adoption. Customer concentration, supply constraints, competition from larger chipmakers and uncertainty around long-term AI spending all remain central concerns for investors evaluating CBRS stock.
The IPO also arrived during a broad rally in semiconductor and AI-linked equities. That backdrop can lift new listings quickly, but it can also magnify downside if sentiment turns. For retail investors searching for Cerebras stock price updates, the early trading pattern shows both the appeal and the danger of buying into a hot IPO immediately after listing.
What Cathie Wood’s Move Means For Investors
Wood’s semiconductor stock sale is likely to be read less as a retreat from artificial intelligence and more as a shift in how ARK wants exposure to the theme. AMD remains a major AI and data-center player, but Cerebras offers a higher-risk, higher-upside profile tied to a newer public company with a more concentrated AI chip story.
That distinction matters. Established semiconductor companies usually offer broader revenue bases, deeper customer relationships and more liquid trading histories. Cerebras offers a cleaner growth narrative but also less public evidence about how it will perform across market cycles.
For investors, the key question is not simply whether AI demand continues to grow. It is whether Cerebras can convert technical differentiation into durable revenue, reliable margins and customer scale while competing against some of the best-capitalized companies in the world.
CBRS IPO Puts AI Valuations Back In Focus
The Cerebras IPO has quickly become a reference point for the next phase of the AI market. Its first-day pop showed that investors still have a strong appetite for artificial intelligence infrastructure, even after years of gains in the sector’s biggest names.
ARK’s purchases add another layer of attention because Wood’s funds are closely watched for high-conviction bets in disruptive technology. Still, the early CBRS rally and subsequent pullback show that the market is still searching for a sustainable price.
The next major test will be Cerebras’ first public earnings cycle and any updates on customer demand, production capacity and profitability. Until then, the stock is likely to remain a volatile proxy for investor confidence in the broader AI chip trade.
